Features of peripheral blood cellular immunity parameters in patients with lung damage up to 30 % in COVID-19

Q4 Immunology and Microbiology
E. A. Borodulina, Zh. P. Vasneva, E. S. Vdoushkina, B. E. Borodulin, L. V. Povalyaeva
{"title":"Features of peripheral blood cellular immunity parameters in patients with lung damage up to 30 % in COVID-19","authors":"E. A. Borodulina, Zh. P. Vasneva, E. S. Vdoushkina, B. E. Borodulin, L. V. Povalyaeva","doi":"10.29413/abs.2023-8.4.11","DOIUrl":null,"url":null,"abstract":"Background . The stability of human organism for different kind of infection, including SARS-CoV-2 is significantly defined by the immune system. The mechanisms of the cellular immunity to the SARS-CoV-2 are not exactly defined and are under study. The aim . To study the features of cell immunity parameters in patients with lung damage up to 30 % in COVID-19. Material and methods . 73 people were examined during the 2020–2021 pandemic. The study group consisted of 31 patients with lung damage up to 30 % with COVID-19, the comparison group consisted of 42 people not infected with SARS-CoV-2. A complete clinical blood count was carried out using a Medonic M20 hematological analyzer (Boule Medical, Sweden), the level of lymphocyte subpopulations was determined using a FACS Calibur cytometer (BD, USA) and FITC- and phycoerythrin-labeled monoclonal antibodies (Sorbent, Russia). Differences were considered statistically significant at p < 0.05. Results . Patients with COVID-19 with lung damage according to computed tomography (CT) ≤ 30 % before the treatment had a restructuring in the ratio of lymphocyte subpopulations in 67.7 % of cases. Lymphopenia (< 1.1 × 10 9 cells/l) was detected in 34.4 % of patients: a decrease in the absolute count of CD3 + lymphocytes by 30.8 %, CD3 + CD4 + – by 35 %, CD3 + CD8 + – by 6.7 % (p < 0.05), CD16 + CD56 + natural killer (NK) cells – by 29.4 % (p = 0.009). The level of CD95 + lymphocytes in COVID-19 is 3.2 times higher than in healthy individuals. Elevated levels of HLA-DR + - (> 20 %) and CD3 + HLADR + lymphocytes (> 6 %) are recorded in 60 % and 86.7 % of patients, respectively. Elevated levels of CD19 + B lymphocytes (> 17 %) in COVID-19 are 2.6 times more common than in healthy individuals. Correlation dependences of the count of NK cells with a wide range of T lymphocyte subpopulations were revealed. Conclusion . Cellular immunity indicators in COVID-19 have a number of features that can serve as predictors of the progression of the severity of the disease.","PeriodicalId":32463,"journal":{"name":"Acta Biomedica Scientifica","volume":"38 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Biomedica Scientifica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29413/abs.2023-8.4.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

Abstract

Background . The stability of human organism for different kind of infection, including SARS-CoV-2 is significantly defined by the immune system. The mechanisms of the cellular immunity to the SARS-CoV-2 are not exactly defined and are under study. The aim . To study the features of cell immunity parameters in patients with lung damage up to 30 % in COVID-19. Material and methods . 73 people were examined during the 2020–2021 pandemic. The study group consisted of 31 patients with lung damage up to 30 % with COVID-19, the comparison group consisted of 42 people not infected with SARS-CoV-2. A complete clinical blood count was carried out using a Medonic M20 hematological analyzer (Boule Medical, Sweden), the level of lymphocyte subpopulations was determined using a FACS Calibur cytometer (BD, USA) and FITC- and phycoerythrin-labeled monoclonal antibodies (Sorbent, Russia). Differences were considered statistically significant at p < 0.05. Results . Patients with COVID-19 with lung damage according to computed tomography (CT) ≤ 30 % before the treatment had a restructuring in the ratio of lymphocyte subpopulations in 67.7 % of cases. Lymphopenia (< 1.1 × 10 9 cells/l) was detected in 34.4 % of patients: a decrease in the absolute count of CD3 + lymphocytes by 30.8 %, CD3 + CD4 + – by 35 %, CD3 + CD8 + – by 6.7 % (p < 0.05), CD16 + CD56 + natural killer (NK) cells – by 29.4 % (p = 0.009). The level of CD95 + lymphocytes in COVID-19 is 3.2 times higher than in healthy individuals. Elevated levels of HLA-DR + - (> 20 %) and CD3 + HLADR + lymphocytes (> 6 %) are recorded in 60 % and 86.7 % of patients, respectively. Elevated levels of CD19 + B lymphocytes (> 17 %) in COVID-19 are 2.6 times more common than in healthy individuals. Correlation dependences of the count of NK cells with a wide range of T lymphocyte subpopulations were revealed. Conclusion . Cellular immunity indicators in COVID-19 have a number of features that can serve as predictors of the progression of the severity of the disease.
新冠肺炎患者高达30%肺损伤患者外周血细胞免疫参数特征
背景。人类机体对包括SARS-CoV-2在内的不同类型感染的稳定性在很大程度上取决于免疫系统。细胞对SARS-CoV-2的免疫机制尚不明确,尚在研究中。目标。目的:研究新冠肺炎患者肺损伤达30%患者的细胞免疫参数特征。材料和方法。在2020-2021年大流行期间,有73人接受了检查。研究组由31名肺损伤高达30%的COVID-19患者组成,对照组由42名未感染SARS-CoV-2的患者组成。使用Medonic M20血液分析仪(瑞典Boule Medical)进行完整的临床血液计数,使用FACS Calibur细胞仪(BD,美国)和FITC和植物红蛋白标记的单克隆抗体(Sorbent,俄罗斯)测定淋巴细胞亚群水平。p <认为差异有统计学意义;0.05. 结果。治疗前CT检查≤30%的新冠肺炎肺损伤患者淋巴细胞亚群比例重构率为67.7%。淋巴细胞减少(& lt;1.1 × 10 9细胞/l), 34.4%的患者检测到CD3 +淋巴细胞绝对计数下降30.8%,CD3 + CD4 + -绝对计数下降35%,CD3 + CD8 + -绝对计数下降6.7% (p <CD16 + CD56 +自然杀伤(NK)细胞-减少29.4% (p = 0.009)。COVID-19患者的CD95 +淋巴细胞水平比健康人高3.2倍。HLA-DR + - (>20%)和CD3 + HLADR +淋巴细胞(>分别为60%和86.7%。CD19 + B淋巴细胞水平升高(>在COVID-19中的发病率是健康人的2.6倍。NK细胞计数与广泛的T淋巴细胞亚群的相关性依赖性被揭示。结论。COVID-19的细胞免疫指标具有许多特征,可以作为疾病严重程度进展的预测指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Biomedica Scientifica
Acta Biomedica Scientifica Immunology and Microbiology-General Immunology and Microbiology
CiteScore
0.40
自引率
0.00%
发文量
106
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信